all report title image

POLIOMYCETES VACCINE IN DRAGEE CANDY MARKET ANALYSIS

Poliomycetes Vaccine in Dragee Candy Market, by Vaccine Type (Type I Poliovirus Infection, and Type II Poliovirus Infection), by Application (Hospitals, Clinics, and Medical Centers), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Dec 2024
  • Code : CMI2310
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Poliomycetes Vaccine In Dragee Candy MarketSize and Trends

Poliomycetes Vaccine in Dragee Candy Market – Drivers

Rising number of mergers and acquisitions of key players in the poliovirus vaccine industry is expected to rise growth of the poliomycetes vaccine in dragee candy market. For instance, in April 2017, Serum Institute of India Pvt. Ltd., acquired Nanotherapeutics, a Czech company for US $ 82.08 million. This acquisition by Serum Institute aided in expanding injectable polio vaccine manufacturing capacity to 200 million dosages, making the company the largest manufacturers of polio vaccines in the world.

Furthermore, in July 2018, Bharat Biotech announced to develop polio vaccine against type I and III viruses. Bharat Biotech is looking at combination vaccines inclusive of the Sabin Inactivated Polio Vaccine (sIPV) for successful eradication of poliovirus. Such robust manufacturing of vaccines against poliovirus will be helpful in driving growth of the market.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.